pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,031 catalysts · 5,347 phase readout · 2,338 8k filing · 343 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 0 catalysts2026-07-31: 0 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,338
  • pdufa343
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07225647: A Study to Assess the Effect of Food on the Drug Levels of Admilparant

Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Participants

full page →ctgov ↗
›COMPLETEDphase readoutNCT06459947: Effect of Cyanoacrylate and Concentrated Growth Factor on Palatal Donor Site

Sponsor: Yuzuncu Yil University. Phase: NA. Conditions: Wound Healing, Pain, Patient Comfort

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07498647: Clinical Trial of BR2251 Tablets for Patients With Primary Gout and Hyperuricemia

Sponsor: BioRay Pharmaceutical Co., Ltd.. Phase: PHASE2. Conditions: Gout and Hyperuricemia

full page →ctgov ↗
›TERMINATEDphase readoutNCT05341349: Stereotactic Radiosurgery and Immune Checkpoint Inhibitors With NovoTTF-200M for the Treatment of Melanoma Brain Metastases

Sponsor: Emory University. Phase: PHASE1. Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Neoplasm in the Brain, Metastatic Melanoma, Metastatic Mucosal Melanoma, Metastatic Ocular Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8

full page →ctgov ↗
›RECRUITINGphase readoutNCT07470749: Frequency of MAFLD and Its Association With Nutritional Status and Metabolic Risk Factors in a Rural Population of Bangladesh

Sponsor: Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh. Phase: . Conditions: MAFLD, Metabolic Abnormalities, Obesity & Overweight

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04837833: An Ultrasound Imaging Technique to Measure Tumors in People With Pancreatic Ductal Adenocarcinoma (PDAC) or Gastrointestinal (GI) Adenocarcinoma

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Pancreas Cancer, Gastrointestinal Adenocarcinoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05306938: Adolescent Wellness Visits in Tanzania

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: HIV Testing, Contraceptive Usage

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07489352: N-of-1 Trial to Promote Beta-Blocker Titration in Heart Failure

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Heart Failure, Beta-blocker, Older Adults

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07523152: Assessment of Sexual Quality of Life Following Local Treatment (Radiotherapy With or Without Surgery) in Patients With HPV-positive Pelvic Cancer: a Descriptive Longitudinal Study

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Pelvic Cancer, Anal Cancer, Vaginal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT04279158: Attention Modulation of Local and Global Inhibition Mechanisms

Sponsor: Hospices Civils de Lyon. Phase: NA. Conditions: Optical Phenomena

full page →ctgov ↗
›RECRUITINGphase readoutNCT07118358: BIOTRONIK Investigation of the LivIQ Leadless Pacemaker System

Sponsor: Biotronik, Inc.. Phase: NA. Conditions: Leadless Pacemaker, Bradycardia, AV Block, Cardiac Rhythm Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT04395131: Clearum High Flux Hemodialyzer Used in Hemodialysis for Subjects With End-Stage Renal Disease

Sponsor: Mozarc Medical US LLC. Phase: NA. Conditions: End-stage Renal Disease

full page →ctgov ↗
›COMPLETEDphase readoutNCT07386145: Frequency and Voluntary Contraction-Dependent Activation of Tonic Vibration Reflex and Bone Myoregulation Reflex

Sponsor: Istanbul Physical Medicine Rehabilitation Training and Research Hospital. Phase: NA. Conditions: Whole Body Vibration

full page →ctgov ↗
›TERMINATEDphase readoutNCT01424345: The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient

Sponsor: CAMC Health System. Phase: PHASE4. Conditions: Kidney Transplant Immunosuppression

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07474272: Non-Surgical Treatment of Periodontitis With Adjunctive Sodium Hypochlorite/Amino Acids and Cross-Linked Hyaluronic Acid

Sponsor: Marwan El Mobadder. Phase: NA. Conditions: Periodontitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02879175: Patients' Follow-up After Subarachnoid Haemorrhage Caused by Ruptured Intracranial Aneurysms

Sponsor: Fondation Ophtalmologique Adolphe de Rothschild. Phase: . Conditions: Intracranial Aneurysms

full page →ctgov ↗
›COMPLETEDphase readoutNCT05669001: A Study of TCD601 in de Novo Renal Transplant Recipients

Sponsor: ITB-Med LLC. Phase: PHASE2. Conditions: Renal Transplantation

full page →ctgov ↗
›COMPLETEDphase readoutNCT06407193: Gastric Emptying After Sleeve Gastrectomy

Sponsor: Rijnstate Hospital. Phase: . Conditions: Gastric Emptying, Bariatric Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT07433621: Quercetin in Patients With XIAP (X-linked Inhibitor of Apoptosis) Deficiency

Sponsor: Children's Hospital Medical Center, Cincinnati. Phase: PHASE1. Conditions: XIAP Deficiency

full page →ctgov ↗
›COMPLETEDphase readoutNCT02583893: Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University. Phase: PHASE2. Conditions: Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01719016: Improvement Assessment of Coronary Flow Dysfunction Using Fundamental Fluid Dynamics

Sponsor: University of Cincinnati. Phase: . Conditions: Coronary Artery Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07435506: Effects of Feedback and Aging on Aiming Movements in Virtual Reality

Sponsor: Aix Marseille Université. Phase: NA. Conditions: Healthy Older Adults, Healthy Young Adults

full page →ctgov ↗
›RECRUITINGphase readoutNCT07323706: Ayurvedic Diet in Myxedema

Sponsor: University of Copenhagen. Phase: NA. Conditions: Hypothyroidism Primary

full page →ctgov ↗
›RECRUITINGphase readoutNCT07453004: A Study to Evaluate the Efficacy,Safety,Tolerability,Pharmacokinetics,and Immunogenicty of Plonmarlimab in Subjects With Acute Gouty Arthritis

Sponsor: TJ Biopharma Co., Ltd.. Phase: PHASE2. Conditions: Acute Gouty Arthritis

full page →ctgov ↗
›COMPLETEDphase readoutNCT05170984: MAtrix Therapy for Hard-to-heal ChrOnic Wounds

Sponsor: Organ, Tissue, Regeneration, Repair and Replacement. Phase: NA. Conditions: Chronic Ulcer of Leg or Foot, Diabetic Foot Ulcer, Arterial Ulcer, Venous Ulcer of Leg

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06011252: Pacing Characteristics of a Conventional Bipolar

Sponsor: Chang Gung Memorial Hospital. Phase: NA. Conditions: Symptomatic Bradycardia

full page →ctgov ↗
›COMPLETEDphase readoutNCT07398547: The Effect of Training Frequency on Explosive Strength in Adolescent Tennis Players During a Six-Week Functional Training Program

Sponsor: Biruni University. Phase: NA. Conditions: Exercise Therapy

full page →ctgov ↗
›COMPLETEDphase readoutNCT07506447: The Value of [18F]FDG PET/CT Imaging in Prognostic Evaluation of Mucosal Melanoma

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: . Conditions: FDG PET, Mucosal Melanoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT05176847: The Mobile Lifestyle Intervention for Food and Exercise Study

Sponsor: University of South Carolina. Phase: NA. Conditions: Overweight and Obesity, Type2 Diabetes

full page →ctgov ↗
›COMPLETEDphase readoutNCT07364149: Acute Effects of Structured Exercise and Static Stretching on Vascular Function, Neuromuscular Performance, and Metabolic Regulation in Adults

Sponsor: University of Palermo. Phase: NA. Conditions: Healthy, Healthy Participants, Healthy Subjects (HS), Resistance Training Adaptation, Static Stretching, Stretch

full page →ctgov ↗
›RECRUITINGphase readoutNCT07457749: Clinical Performance of a Novel Self-cured Resin Composite Compared to a Light-cured Bioactive Resin Composite Restoration in Proximal Cavities of Posterior Teeth

Sponsor: British University In Egypt. Phase: EARLY_PHASE1. Conditions: Proximal Cavities of Posterior Teeth

full page →ctgov ↗
›RECRUITINGphase readoutNCT07169448: Food is Medicine Prospective Study

Sponsor: Cedars-Sinai Medical Center. Phase: . Conditions: Wounds and Injuries

full page →ctgov ↗
›RECRUITINGphase readoutNCT07538648: A Phase II Clinical Study Evaluating the Effectiveness of Injectable NC527-X in Intraoperative Imaging for Patients With Solid Tumors

Sponsor: Zhejiang Cancer Hospital. Phase: PHASE1. Conditions: Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03970655: Functional Endoscopic Sinus Surgery Study

Sponsor: University of Florida. Phase: PHASE1. Conditions: Chronic Rhinosinusitis (Diagnosis)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04662255: Study of BTK Inhibitor LOXO-305 Versus Approved BTK Inhibitor Drugs in Patients With Mantle Cell Lymphoma (MCL)

Sponsor: Loxo Oncology, Inc.. Phase: PHASE3. Conditions: Lymphoma, Mantle-Cell

full page →ctgov ↗
›RECRUITINGphase readoutNCT06077643: Workshops and Exchange Groups for Laryngectomized Patients

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Laryngectomy; Status, Laryngeal Cancer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04936308: Guselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha Agent

Sponsor: Janssen Research & Development, LLC. Phase: PHASE3. Conditions: Arthritis, Psoriatic

full page →ctgov ↗
›RECRUITINGphase readoutNCT07571317: Combined Predictive Value of RSBI and CALLY Index in Predicting Weaning Success in ICU Patients

Sponsor: Istanbul University - Cerrahpasa. Phase: . Conditions: Critical Illness, Respiratory Insufficiency, Ventilator Weaning, Weaning Failure of Mechanical Ventilation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07164040: Leica Microsystems Sponsored Study to Collect and Confirm Clinical Data on the Performance of the GLOW800 Device When Used in Accordance With Its Intended Use.

Sponsor: Leica Microsystems (Schweiz) AG. Phase: . Conditions: Reconstructive Surgical Procedures, Plastic Surgery, Vascular Surgical Procedure, Cerebrovascular Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07361640: DiaMester Pilot RCT: E-health Lifestyle Program for Type 2 Diabetes

Sponsor: Oslo University Hospital. Phase: NA. Conditions: Diabetes Mellitus, Type 2

full page →ctgov ↗
›COMPLETEDphase readoutNCT03981289: Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)

Sponsor: Virginia Commonwealth University. Phase: . Conditions: Limb Girdle Muscular Dystrophy, Muscular Dystrophies

full page →ctgov ↗
›RECRUITINGphase readoutNCT07510789: Impact of Low Back Pain Phenotypes on Function and Quality of Life in Ankylosing Spondylitis

Sponsor: Konya Beyhekim Training and Research Hospital. Phase: . Conditions: Ankylosing Spondylitis, Low Back Pain

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT01907789: Prophylactic Salpingectomy With Delayed Oophorectomy

Sponsor: M.D. Anderson Cancer Center. Phase: NA. Conditions: Ovarian Carcinoma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07090291: China Colorectal Cancer Screening Trial 1 (C-Cost1)

Sponsor: Zhejiang University. Phase: NA. Conditions: Colorectal Cancer, Advanced Adenoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07307690: 8 Weeks vs 12 Weeks Physical Exercise Programmes in Colorectal Cancer Patients

Sponsor: University of Salamanca. Phase: NA. Conditions: Oncology, Chemotherapy-Induced Peripheral Neuropathy

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07463690: Construction and Evaluation of a Flipped Discharge Model for Stomates With Colorectal Cancer

Sponsor: Sun Yat-sen University. Phase: NA. Conditions: Colorectal Cancer, Stoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07604597: A Digital Stewardship Strategy for Patients With Reported Penicillin Allergy

Sponsor: Althaia Xarxa Assistencial Universitària de Manresa. Phase: . Conditions: Penicillin Allergy, In-hospital Process Optimization

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05757713: Teplizumab in Pediatric Stage 2 Type 1 Diabetes

Sponsor: Sanofi. Phase: PHASE4. Conditions: Diabetes Mellitus, Type 1

full page →ctgov ↗
›RECRUITINGphase readoutNCT07268560: Real-World Effectiveness of Aztreonam-Avibactam Against MBL-Producing CRE

Sponsor: Sir Run Run Shaw Hospital. Phase: . Conditions: Complicated Intra-Abdominal Infections, cIAIs, Hospital-acquired Pneumonia (HAP), Ventilator-Associated Pneumonia (VAP)

full page →ctgov ↗
›WITHHELDphase readoutNCT05479513: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
← prev
page 90 of 161
next →